Le Lézard
Classified in: Health
Subject: SVY

The antimicrobial preservatives market will register a CAGR of over 4% by 2023

NEW YORK, March 19, 2019 /PRNewswire/ -- About this market
Antimicrobial preservatives are used in different product life cycles, which include manufacturing, processing, and packaging, to prevent microbial growth. Antimicrobial packaging is a system that is designed to incorporate antimicrobial substances into the packaging films to inhibit the growth of microorganisms that are involved in contaminating products. It helps extend the shelf life and safety of packaged products. The antimicrobial packaging industry is driven by the growing consumer awareness about health-related issues, consumption of packaged foods, and increased use of novel food-grade materials by vendors for packaging to improve their sales. Hence, with the rising use of antimicrobial packaging in various industries, the sales of antimicrobial preservatives will increase during the forecast period. Analysts have predicted that the antimicrobial preservatives market will register a CAGR of over 4% by 2023.

Read the full report: https://www.reportlinker.com/p05756629/?utm_source=PRN

Market Overview
Demand for novel solutions to optimize food supply chains
Import of food products is increasing worldwide due to availability and consumer demand for diverse food products. Globalization has increased consumer access to a wide range of F&B products. However, F&B products require special conditions during distribution as they are prone to microbial contamination, which can affect their safety, quality, and authenticity. Food safety and preservation during food distribution can be increased by optimizing the food supply chain.
Use of sub-grade preservatives in counterfeit products
Counterfeit preservatives can affect brand images of companies and compromise the quality of treatments provided to patients, thereby affecting the health of patients. Thus, counterfeit products may pose a major challenge to the growth of the market.
For the detailed list of factors that will drive and challenge the growth of the antimicrobial preservatives market during the 2019-2023, view our report.

Competitive Landscape
The market appears to be moderately fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Read the full report: https://www.reportlinker.com/p05756629/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

These press releases may also interest you

at 08:20
Veran Medical continues its mission to help physicians diagnose and treat early stage lung cancer with the launch of two, new navigated instruments. These devices are designed to help diagnose and guide treatment of small suspicious nodules, likely...

at 08:17
Amygdala Neurosciences (a private company) has been awarded up to $1.35 million NIH grant support for the project titled "26- & 39-Week Toxicity Studies of ANS-6637 in Rats and Monkeys (respectively) to Enable 6+ Months Dosing in Alcohol (and other...

at 08:15
Shady Grove Fertility (SGF), a leader in reproductive medicine, will be hosting a complimentary patient seminar in the UK to discuss their renowned International Donor Egg Program. Shady Grove Fertility Founder and UK Program Director, Michael J....

at 08:15
The "Phosphoglucomutase (PGM 1) Deficiency - Market Insights, Epidemiology and Market Forecast - 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. Phosphoglucomutase (PGM 1) Deficiency - Market Insights, Epidemiology and...

at 08:15
China has been the world's biggest producer and consumer of human vaccines over four decades of planned vaccination, a program that has reduced incidence of multiple vaccine-targeted infectious diseases to the lowest level. Read the full report:...

at 08:12
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new two-year data from the long-term extension of the Phase 3 UNIFI study. The data demonstrated that the majority of adult patients with moderately to severely active...

News published on 19 march 2019 at 18:01 and distributed by: